MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 169 filers reported holding MEDICINES CO in Q4 2014. The put-call ratio across all filers is 1.96 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $686,000 | +73.7% | 8,071 | -39.0% | 0.06% | +357.1% |
| Q3 2018 | $395,000 | +58.6% | 13,222 | +44.9% | 0.01% | +40.0% |
| Q4 2017 | $249,000 | -20.7% | 9,122 | +7.6% | 0.01% | -16.7% |
| Q3 2017 | $314,000 | +10.6% | 8,477 | +13.3% | 0.01% | +9.1% |
| Q2 2017 | $284,000 | +35.2% | 7,481 | -0.3% | 0.01% | +57.1% |
| Q1 2015 | $210,000 | -79.5% | 7,504 | -83.7% | 0.01% | -77.4% |
| Q3 2014 | $1,026,000 | -2.4% | 45,962 | +24.2% | 0.03% | +10.7% |
| Q1 2014 | $1,051,000 | +164.1% | 36,996 | +185.6% | 0.03% | +115.4% |
| Q2 2013 | $398,000 | – | 12,952 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 4,202,000 | $356,917,000 | 29.62% |
| SYQUANT CAPITAL SAS | 505,030 | $42,897,000 | 22.09% |
| Moab Capital Partners | 521,987 | $44,338,000 | 17.51% |
| Antipodean Advisors LLC | 321,000 | $27,266,000 | 15.60% |
| RAMIUS ADVISORS LLC | 419,826 | $35,660,000 | 15.34% |
| DLD Asset Management, LP | 3,275,900 | $278,255,000 | 15.00% |
| Foresite Capital Management IV, LLC | 403,217 | $34,249,000 | 14.78% |
| WHITE SQUARE CAPITAL LLP | 239,331 | $20,329,000 | 14.70% |
| Davide Leone & Partners Investment Co Ltd. | 1,146,192 | $97,358,000 | 12.50% |
| Quad Capital Management Advisors LLC | 8,640 | $734,000 | 11.19% |